Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH With Fibrosis”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Testing effectiveness (Phase 2)Study completedNCT02217475
What this trial is testing

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 289
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Testing effectiveness (Phase 2)Study completedNCT04173065
What this trial is testing

Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Viking Therapeutics, Inc. 248
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableWithdrawnNCT02658786
What this trial is testing

Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease

Who this might be right for
HBVNAFLDHCV
Institute of Liver and Biliary Sciences, India
Not applicableUnknownNCT05257200
What this trial is testing

Gut Permeability and Bariatric-metabolic Surgery

Who this might be right for
NASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability
Medical University of Vienna 125
Not applicableActive Not RecruitingNCT04861571
What this trial is testing

Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD

Who this might be right for
NAFLD
University of Iowa 20
Testing effectiveness (Phase 2)UnknownNCT03205345
What this trial is testing

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Conatus Pharmaceuticals Inc. 210
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Large-scale testing (Phase 3)Study completedNCT00655018
What this trial is testing

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
InflammationFibrosisInsulin Resistance
Bambino Gesù Hospital and Research Institute 90
Testing effectiveness (Phase 2)Study completedNCT00885313
What this trial is testing

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Load More Results